These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 28129301)
1. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia. Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301 [TBL] [Abstract][Full Text] [Related]
2. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Sinha B; Kumar R Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194 [TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Boehm MD; Huang AJ Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia. Venkateswaran N; Mercado C; Galor A; Karp CL Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241 [TBL] [Abstract][Full Text] [Related]
5. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688 [TBL] [Abstract][Full Text] [Related]
6. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578 [TBL] [Abstract][Full Text] [Related]
7. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]
8. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary? Chaugule SS; Park J; Finger PT Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124 [TBL] [Abstract][Full Text] [Related]
14. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499 [TBL] [Abstract][Full Text] [Related]
15. Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration. Shields CL; Constantinescu AB; Paulose SA; Yaghy A; Dalvin LA; Shields JA; Lally SE Indian J Ophthalmol; 2021 Mar; 69(3):563-567. PubMed ID: 33595473 [TBL] [Abstract][Full Text] [Related]
16. Surgical versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Cost Comparison. Moon CS; Nanji AA; Galor A; McCollister KE; Karp CL Ophthalmology; 2016 Mar; 123(3):497-504. PubMed ID: 26686965 [TBL] [Abstract][Full Text] [Related]
17. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Sturges A; Butt AL; Lai JE; Chodosh J Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690 [TBL] [Abstract][Full Text] [Related]
18. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes. Agarwal A; Ghose N; Rathi V; Khanna R; Kaliki S BMC Ophthalmol; 2024 Sep; 24(1):389. PubMed ID: 39227791 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia. Kato JM; Ballalai PL; de Lima PP; Santo RM Can J Ophthalmol; 2024 Oct; 59(5):e510-e514. PubMed ID: 38631493 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes. Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]